Affiliation:
1. Center for Vaccine Development, Departments of Medicine, Pediatrics, and Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, Maryland 21201
Abstract
SUMMARY
Escherichia coli is the predominant nonpathogenic facultative flora of the human intestine. Some E. coli strains, however, have developed the ability to cause disease of the gastrointestinal, urinary, or central nervous system in even the most robust human hosts. Diarrheagenic strains of E. coli can be divided into at least six different categories with corresponding distinct pathogenic schemes. Taken together, these organisms probably represent the most common cause of pediatric diarrhea worldwide. Several distinct clinical syndromes accompany infection with diarrheagenic E. coli categories, including traveler’s diarrhea (enterotoxigenic E. coli), hemorrhagic colitis and hemolytic-uremic syndrome (enterohemorrhagic E. coli), persistent diarrhea (enteroaggregative E. coli), and watery diarrhea of infants (enteropathogenic E. coli). This review discusses the current level of understanding of the pathogenesis of the diarrheagenic E. coli strains and describes how their pathogenic schemes underlie the clinical manifestations, diagnostic approach, and epidemiologic investigation of these important pathogens.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference724 articles.
1. Escherichia coli O157:H7 generates a unique biochemical profile on MicroScan conventional gram-negative identification panels
2. Evaluation of a non-radioactive chemiluminescent method for using oligonucleotide and polynucleotide probes to identify enterotoxigenic Escherichia coli.;Abdul A. A.;J. Diar. Dis. Res.,1994
3. Acheson
D. W. K.
DeBreuker
S.
Donohue-Rolfe
A.
Kozak
K.
Yi
A.
Keusch
G. T.
Development of a clinically useful diagnostic enzyme immunoassay for enterohemorrhagic Escherichia coli infection
Recent advances in verocytotoxin-producing Escherichia coli infections.
Karmali
M. A.
Goglio
A. G.
1994
109
112
Elsevier Science B.V.
Amsterdam The Netherlands
4. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR
5. Translocation of Shiga toxin across polarized intestinal cells in tissue culture.;Acheson D. W. K.;Infect. Immun.,1992
Cited by
3435 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献